Haemophiliacs, until recently, have been at risk of hepatitis B and C infection. Substantial numbers of patients remain persistently infected. Several lines of evidence suggest that these diseases will cause considerable morbidity unless therapy can successfully reduce viraemia and prevent disease progression. Cessation of viral replication may prevent progression to hepatic fibrosis.
No takes yet. Share an insight, caveat, or question.
Lee et al. (1998) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: